By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous anxiolytics, sedatives and hypnotics > Xyrem > Xyrem Side Effects
Miscellaneous anxiolytics, sedatives and hypnotics

Xyrem Side Effects

Note: This document contains side effect information about sodium oxybate. Some dosage forms listed on this page may not apply to the brand name Xyrem.

Summary

Common side effects of Xyrem include: dizziness and nausea. Continue reading for a comprehensive list of adverse effects.

Applies to sodium oxybate: oral powder for suspension extended release, oral solution.

Warning

Oral route (Solution)

Warning: Central Nervous System (CNS) Depression and Abuse and MisuseCentral Nervous System DepressionSodium oxybate is a CNS depressant. In clinical trials at recommended doses, obtundation and clinically significant respiratory depression occurred in adult patients treated with sodium oxybate. Many patients who received sodium oxybate during clinical trials in narcolepsy were receiving central nervous system stimulants.Abuse and MisuseSodium oxybate is the sodium salt of gamma-hydroxybutyrate (GHB). Abuse or misuse of illicit GHB, either alone or in combination with other CNS depressants, is associated with CNS adverse reactions, including seizure, respiratory depression, decreases in the level of consciousness, coma, and death.Because of the risks of CNS depression and abuse and misuse, sodium oxybate is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Xywav and Xyrem REMS.

Oral route (Powder for Suspension, Extended Release)

Warning: Central Nervous System Depression and Misuse and AbuseCentral Nervous System (CNS) DepressionSodium oxybate is a CNS depressant. Clinically significant respiratory depression and obtundation may occur in patients treated with sodium oxybate. Many patients who received sodium oxybate during clinical trials in narcolepsy were receiving central nervous system stimulants.Abuse and MisuseSodium oxybate is the sodium salt of gamma-hydroxybutyrate (GHB). Abuse or misuse of illicit GHB, either alone or in combination with other CNS depressants, is associated with CNS adverse reactions, including seizure, respiratory depression, decreases in the level of consciousness, coma, and death.Because of the risks of CNS depression and abuse and misuse, sodium oxybate is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Lumryz REMS.

Serious side effects of Xyrem

Along with its needed effects, sodium oxybate (the active ingredient contained in Xyrem) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking sodium oxybate:

More common

  • Bedwetting
  • sleep walking

Less common

  • Burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • changes in behavior
  • choking or gasping sounds
  • daytime sleepiness or tiredness
  • headache
  • lack of appetite
  • loud or frequent snoring
  • rapid weight gain
  • seeing, hearing, or feeling things that are not there
  • thoughts of killing oneself
  • trouble sleeping
  • unusual weight gain or loss
  • waking to urinate at night

Incidence not known

  • Being forgetful
  • blurred vision
  • decrease in the amount of urine
  • dizziness
  • fever
  • hives, itching, skin rash
  • hoarseness
  • increase urge to urinate at night
  • irritation
  • joint pain, stiffness, or swelling
  • nervousness
  • noisy, rattling breathing
  • pounding in the ears
  • redness of the skin
  • swelling of the face, fingers, hands, feet, or lower legs
  • tightness in the chest
  • trouble breathing or swallowing
  • weight gain

Get emergency help immediately if any of the following symptoms of overdose occur while taking sodium oxybate:

Symptoms of overdose

  • Agitation
  • bluish lips or skin, not breathing
  • chest pain or discomfort
  • clumsiness
  • confusional, agitated combative state
  • drowsiness
  • generalized slowing of mental and physical activity
  • inability to hold bowel movement or urine
  • increased sweating
  • lightheadedness, dizziness, or fainting
  • loss of consciousness
  • muscle aches or weakness
  • seizures
  • shakiness and unsteady walk
  • shivering
  • slow or irregular heartbeat
  • trembling or other problems with muscle control or coordination
  • unusual tiredness or weakness
  • weak or feeble pulse

Other side effects of Xyrem

Some side effects of sodium oxybate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Diarrhea
  • difficulty passing urine (dribbling)
  • increased frequency, urgency, or burning on urination
  • increased sweating
  • nausea
  • vomiting

Less common

  • Dry mouth

Incidence not known

  • Difficulty with moving

For Healthcare Professionals

Applies to sodium oxybate: oral liquid, oral powder for reconstitution extended release.

General

The most commonly reported side effects included dizziness, headache, nausea, and enuresis.[Ref]

Nervous system

Very common (10% or more): Dizziness (up to 20%), headache (up to 20%)

Common (1% to 10%): Balance disorder, cataplexy, disturbance in attention, dysgeusia, hypoesthesia, paresthesia, sedation, sleep paralysis, somnolence, tremor, vertigo

Uncommon (0.1% to 1%): Amnesia, myoclonus, restless legs syndrome

Frequency not reported: Central nervous system depression, convulsion, dyskinesia, loss of consciousness

Postmarketing reports: Memory impairment[Ref]

Disturbance in attention and paresthesia were dose-related, with the side effects occurring more frequently at 9 g/day.[Ref]

Gastrointestinal

Very common (10% or more): Nausea (up to 20%), vomiting (up to 11%)

Common (1% to 10%): Abdominal pain upper, diarrhea, dry mouth, upper abdominal pain

Uncommon (0.1% to 1%): Fecal incontinence[Ref]

Nausea and vomiting were dose-related, with the side effects occurring more frequently at 9 g/day.

The frequency of nausea was higher in women than in men.[Ref]

Psychiatric

Very common (10% or more): Enuresis (up to 19%)

Common (1% to 10%): Abnormal dreams, acute psychosis, anxiety, confusional state, depression, disorientation, enuresis nocturna, insomnia, irritability, middle insomnia, nervousness, nightmares, sleep disorder, sleepwalking, suicidal ideation

Uncommon (0.1% to 1%): Abnormal thinking, agitation, hallucination, initial insomnia, paranoia, psychosis, suicide attempt

Frequency not reported: Abuse, affect lability, aggression, bipolar disorder, bruxism, delusion, euphoric mood, homicidal ideation, increased libido, mania, other behavioral adverse reactions, other psychiatric adverse reactions, parasomnias, psychotic disorders, panic attack, sleep-disordered breathing, sleep-related eating disorder, suicidality, tactile hallucination

Postmarketing reports: Abnormal behavior, mood alteration[Ref]

Disorientation, enuresis, irritability, and sleepwalking were dose-related, with the side effects occurring more frequently at 9 g/day.[Ref]

Metabolic

Very common (10% or more): Weight decreased (up to 13%)

Common (1% to 10%): Anorexia, decreased appetite

Postmarketing reports: Dehydration, fluid retention, increased appetite[Ref]

Respiratory

Common (1% to 10%): Dyspnea, nasal congestion, nasopharyngitis, sinusitis, snoring

Frequency not reported: Choking sensation, respiratory depression, sleep apnea/sleep apnea syndrome[Ref]

Other

Feeling drunk was dose-related, with the side effect occurring more frequently at 9 g/day.[Ref]

Common (1% to 10%): Asthenia, fall, fatigue, feeling drunk, pain

Frequency not reported: Misuse, tinnitus

Postmarketing reports: Hangover[Ref]

Cardiovascular

Common (1% to 10%): Blood pressure increased, hypertension, palpitations, peripheral edema[Ref]

Musculoskeletal

Common (1% to 10%): Arthralgia, back pain, muscle spasms, pain in extremity[Ref]

Dermatologic

Common (1% to 10%): Hyperhidrosis, rash

Frequency not reported: Seborrhea, urticaria[Ref]

Genitourinary

Common (1% to 10%): Urinary incontinence

Frequency not reported: Micturition urgency, nocturia, pollakiuria[Ref]

Ocular

Common (1% to 10%): Blurred vision[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Hypersensitivity

Frequency not reported: Angioedema[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by